Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “E-Therapeutics PLC”

3 pharma patents match "E-Therapeutics PLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "E-Therapeutics PLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “E-Therapeutics PLC” · 30,257 patents in full index Clear search

  1. US 12338438

    Conjugated oligonucleotide compounds, methods of making and uses thereof

    E-Therapeutics PLC · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted

  2. US 10961238

    Modulators of hedgehog (Hh) signaling pathway

    E-Therapeutics PLC · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted

  3. US 8614179

    Antibacterial combination therapy for the treatment of gram positive bacterial infections

    E-Therapeutics PLC · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.